91 related articles for article (PubMed ID: 8209015)
1. Efficacy SH U 508 A (Levovist) as blood pool enhancer in the Doppler evaluation of multiple vascular regions.
Schwarz KQ; Bezante GP; Becher H; Schimpfky C; Vorwerk D; Bogdahn U; Schlief R
Radiol Med; 1994 May; 87(5 Suppl 1):3-14. PubMed ID: 8209015
[TBL] [Abstract][Full Text] [Related]
2. Doppler enhancement with SH U 508A in multiple vascular regions.
Schwarz KQ; Becher H; Schimpfky C; Vorwerk D; Bogdahn U; Schlief R
Radiology; 1994 Oct; 193(1):195-201. PubMed ID: 7916468
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and clinical value of an intravenous echo-enhancement agent in evaluation of high-grade internal carotid stenosis.
Sitzer M; Rose G; Fürst G; Siebler M; Steinmetz H
J Neuroimaging; 1997 Apr; 7 Suppl 1():S22-5. PubMed ID: 9128462
[TBL] [Abstract][Full Text] [Related]
4. Color Doppler flow imaging of renal disease. Value of a new intravenous contrast agent: SH U 508 A (Levovist).
Filippone A; Muzi M; Basilico R; Di Giandomenico V; Trapani AR; Bonomo L
Radiol Med; 1994 May; 87(5 Suppl 1):50-8. PubMed ID: 8209018
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of SH U 508 A (Levovist) in color Doppler ultrasonography of hepatocellular carcinoma vascularization.
Angeli E; Carpanelli R; Crespi G; Zanello A; Sironi S; Del Maschio A
Radiol Med; 1994 May; 87(5 Suppl 1):24-31. PubMed ID: 8209014
[TBL] [Abstract][Full Text] [Related]
6. Color Doppler imaging of liver metastases. The value phase-III of a US contrast agent: SH U 508 A (Levovist) Schering.
Campani R; Bozzini A; Calliada F; Bottinelli O; Anguissola R; Conti MP; Corsi G
Radiol Med; 1994 May; 87(5 Suppl 1):32-40. PubMed ID: 8209016
[TBL] [Abstract][Full Text] [Related]
7. [Ultrasonography contrast media Levovist and power Doppler in the study of the breast. Methodology, vascular morphology and automatic enhancement quantification with wash-in and wash-out curves].
Menna S; Di Virgilio MR; Burke P
Radiol Med; 1999 Jun; 97(6):472-8. PubMed ID: 10478204
[TBL] [Abstract][Full Text] [Related]
8. Saccharide-based contrast agents. Characteristics and diagnostic potential.
Schürmann R; Schlief R
Radiol Med; 1994 May; 87(5 Suppl 1):15-23. PubMed ID: 8209013
[TBL] [Abstract][Full Text] [Related]
9. Ultrasound contrast agent Levovist in colour Doppler sonography of hepatocellular carcinoma in Chinese patients.
Khong PL; Chau MT; Fan ST; Leong LL
Australas Radiol; 1999 May; 43(2):156-9. PubMed ID: 10901894
[TBL] [Abstract][Full Text] [Related]
10. A multicenter, prospective, open label, randomized, controlled phase IIIb study of SH U 508 a (Levovist) for Doppler signal enhancement in the portal vascular system.
Gebel M; Caselitz M; Bowen-Davies PE; Weber S
Ultraschall Med; 1998 Aug; 19(4):148-56. PubMed ID: 9816618
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience with echo-enhanced transcranial Doppler and duplex imaging.
Ries F
J Neuroimaging; 1997 Apr; 7 Suppl 1():S15-21. PubMed ID: 9128461
[TBL] [Abstract][Full Text] [Related]
12. [Contrast enhanced power Doppler sonography: comparison of various administration forms of the ultrasound contrast agent Levovist].
Kratzer W; Kächele V; Merkle E; Mason RA; Büchner M; von Tirpitz C; Pfeiffer M
Rofo; 2000 May; 172(5):443-8. PubMed ID: 10874971
[TBL] [Abstract][Full Text] [Related]
13. Impact of the continuous infusion of Levovist on color Doppler sonography in portal hypertension.
Schiedermaier P; Layer G; Sauerbruch T
AJR Am J Roentgenol; 2002 Jan; 178(1):61-5. PubMed ID: 11756088
[TBL] [Abstract][Full Text] [Related]
14. Renal arteries in patients at risk of renal arterial stenosis: multicenter evaluation of the echo-enhancer SH U 508A at color and spectral Doppler US. Levovist Renal Artery Stenosis Study Group.
Claudon M; Plouin PF; Baxter GM; Rohban T; Devos DM
Radiology; 2000 Mar; 214(3):739-46. PubMed ID: 10715040
[TBL] [Abstract][Full Text] [Related]
15. [Increased signal intensity of velocity measurements in duplex sonography by using the contrast agent levovist: a prospective, randomized study in a fetal sheep model].
Grüssner S; Klingmüller V; Bohle R
Rofo; 2004 Jan; 176(1):91-7. PubMed ID: 14712412
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of bolus and infusion of the ultrasound contrast media levovist for color doppler ultrasound of renal arteries].
Albrecht T; Cosgrove DO; Butler-Barnes J; Jayaram V; Mahler M; Urbank A; Bauer A
Rofo; 2000 Oct; 172(10):824-9. PubMed ID: 11111294
[TBL] [Abstract][Full Text] [Related]
17. Quantitative evaluation of contrast enhanced transcranial Doppler signal using galactose based echo-contrast agent in dogs.
Chung W; Choi H; Lee K; Lee H; Choi M; Yoon J
J Vet Med Sci; 2006 Jun; 68(6):597-601. PubMed ID: 16820717
[TBL] [Abstract][Full Text] [Related]
18. [Use of SHU 508 A Levovist contrast media in the characterization of solid lesions of the breast].
Guazzaroni M; Cossu E; Danese V; Montanaro M; Simonetti G
Radiol Med; 1998; 96(1-2):35-41. PubMed ID: 9819616
[TBL] [Abstract][Full Text] [Related]
19. The Italian experience with SH U 508 A (Levovist) in breast disease.
Spreafico C; Lanocita R; Frigerio LF; Di Tolla G; Garbagnati F; Milella M; Marchianò A; Piragine G; Damascelli B
Radiol Med; 1994 May; 87(5 Suppl 1):59-64. PubMed ID: 8209019
[TBL] [Abstract][Full Text] [Related]
20. [Doppler power with contrast media in the characterization of renal masses].
Ascenti G; Zimbaro G; Mazziotti S; Visalli C; Racchiusa S; Vinci S; Scribano E
Radiol Med; 2000 Sep; 100(3):168-74. PubMed ID: 11148883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
